Rachel Langland

Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAF^<i>V600E</i> mutation

Jeanne Tie, Peter Gibbs, Lara Lipton et al. · International Journal of Cancer · 2010 · 225 citations · Full text

Engineering, Cancer Pathology, Genetics +20

Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma

Harkanwal Halait, Kelli DeMartin, Sweta Shah et al. · Diagnostic Molecular Pathology · 2012 · 145 citations

Braf Gene, Pathology, Tumor Biology +17

Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma

Steven M. Anderson, Kenneth J. Bloom, Dino U. Vallera et al. · Archives of Pathology & Laboratory Medicine · 2012 · 138 citations · Full text

Repression of organizer genes in dorsal and ventral<i>Xenopus</i>cells mediated by maternal XTcf3

Douglas W. Houston, Matthew Kofron, Ernesto Resnik et al. · Development · 2002 · 105 citations

Vegetal Localization of Maternal mRNAs Is Disrupted by VegT Depletion

Janet Heasman, Oliver Wessely, Rachel Langland et al. · Developmental Biology · 2001 · 89 citations

Transcriptional Regulation, Developmental Biology, Genetics +7